Valuation: Sysmex Corporation

Market Cap 927B 5.66B 4.97B 4.62B 4.24B 7.97B 545B 8.1B 54.91B 21.45B 268B 21.25B 20.8B P/E 2027 *
23.2x
P/E 2028 * 18.7x
Enterprise Value 945B 5.77B 5.07B 4.72B 4.33B 8.13B 556B 8.26B 56.01B 21.88B 273B 21.68B 21.21B EV / Sales 2027 *
1.77x
EV / Sales 2028 * 1.66x
Free-Float
72.3%
Yield 2027 *
2.52%
Yield 2028 * 2.64%
1 day+1.26%
1 week-1.35%
Current month+4.05%
1 month+9.17%
3 months+10.47%
6 months-2.21%
Current year-0.81%
1 week 1,494
Extreme 1494
1,646
1 month 1,358.5
Extreme 1358.5
1,646
Current year 1,246
Extreme 1246
1,646
1 year 1,246
Extreme 1246
2,539
3 years 1,246
Extreme 1246
3,243
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-1.35%-39.12%-51.52% 5.59B
+2.49%+2.69%-17.71%-9.80% 175B
+1.16%-0.12%-9.99%-6.38% 105B
+0.80%-0.10%+5.90%+60.66% 59.35B
-1.13%-1.96%+32.11%+56.38% 50.71B
+1.72%-1.48%-15.14%-44.34% 42.15B
+3.44%-2.27% - - 31.82B
+1.28%-6.87%-17.70%-44.11% 27.2B
-5.31%-5.69%+21.05%-10.16% 25.11B
+1.42%-1.74%-5.81%-7.80% 20.53B
Average +0.74%-3.34%-5.16%-6.34% 54.29B
Weighted average by Cap. +1.25%-1.52%-6.08%+0.58%

Financials

2027 *2028 *
Net sales 535B 3.27B 2.87B 2.67B 2.45B 4.6B 315B 4.67B 31.71B 12.39B 155B 12.27B 12.01B 567B 3.46B 3.04B 2.83B 2.59B 4.87B 333B 4.95B 33.57B 13.12B 164B 12.99B 12.71B
Net income 41.22B 252M 221M 206M 189M 355M 24.25B 360M 2.44B 954M 11.92B 945M 925M 49.94B 305M 268M 249M 229M 430M 29.38B 436M 2.96B 1.16B 14.44B 1.15B 1.12B
Net Debt 18.45B 113M 98.97M 92.04M 84.46M 159M 10.85B 161M 1.09B 427M 5.33B 423M 414M 16.07B 98.18M 86.24M 80.2M 73.59M 138M 9.46B 140M 952M 372M 4.65B 369M 361M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
24/07/26 JP¥1,530.00 +1.26% 1,663,800
23/07/26 JP¥1,511.00 -2.45% 2,238,000
22/07/26 JP¥1,549.00 -3.31% 2,539,000
21/07/26 JP¥1,602.00 -1.60% 3,166,200
17/07/26 JP¥1,628.00 +4.96% 5,271,100
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,530.00JPY
Average target price
1,738.57JPY
Spread / Average Target
+13.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock